Ahmed Elkhanany

581 posts

Ahmed Elkhanany banner
Ahmed Elkhanany

Ahmed Elkhanany

@Elkhanany

Assistant Prof of Breast Onc at @BCMCancerCenter. BrCA TME & disparity. Father/Husband. Into R, philosophy, violin, photography & JRPGs. 🧬🥼👨‍👩‍👦‍👦🎮🎻🇪🇬

Houston, TX Katılım Mayıs 2011
1.4K Takip Edilen750 Takipçiler
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@Glitch_Trades I’ve been experimenting with mapping the total Open Interest landscape to track 'legacy' whale positions placed weeks/months ago that still have DTE. XYZ DTE Strike Vol. Idea is longterm conviction. G hedging might not be developed that far out.
English
0
0
1
48
Glitch
Glitch@Glitch_Trades·
Spent some time building out a UI for Talon. For those that don’t know, Talon is an evolution of AgentZero which was our first major step towards full end to end agentic trading. This includes but would not be limited to, research, thesis validation, trade plan, execution, trade monitoring, post trade analysis, reinforcement learning, etc. @SkylitAI will own the full end to end trade lifecycle. We would integrate Flowseeker agents, Heatseeker agents, Research agents, quantitative data, you name it. What would you like to see in addition to the above and what are the painful, time consuming, and frustrating parts of your trading experience today that we could help improve?
Glitch tweet media
Glitch@Glitch_Trades

Shit sorry guys, no session tonight. Had another epiphany and I really need to focus tonight on building.

English
18
8
182
31.9K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@Remzztrades I mean, it WILL dump at some point :D I feel like Bear vs Bull is more of a philosophy and personality types at this point rather than seeing actual data and technicals to make decisions.
English
2
0
3
66
Remz
Remz@Remzztrades·
Hottest market to ever exist and someone out there is telling people to buy puts everyday at open Incredible
English
37
14
408
36.1K
Tito A
Tito A@GnT_Trades·
Good morning, say it with me "This is a new week and I start fresh. I will not carry baggage from last week. I will not compare myself to anyone else's journey. I will focus on my process, my edge, and my growth." Let's go have a great week!
English
7
2
102
3.3K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@doclauravater @RitaNandaMD Agree 💯And these are the least funded. Instead of new 1Mil machine, fix the 10$/hr schedulers and get Pt satisfaction back up.
English
0
0
2
172
Laura Vater, MD, MPH
Laura Vater, MD, MPH@doclauravater·
In healthcare, no amount of personal wellness practices can substitute for appropriate staffing, humane scheduling, efficient clinical workflows, adequate administrative support, or a culture of psychological safety.
English
20
160
674
24K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@VincentRK Money I think one different way to hold all accountable is to “sign” replicability clause where if data were not replicated (like 80% or some threshold) then author is responsible for retraction fees which can be 10x APC As grant $ drying, all PIs will ensure reproducibility
English
0
0
1
305
Heisenberg
Heisenberg@Mr_Derivatives·
🚨 $INTC HITS A NEW ALL TIME HIGH. Wild. Where’s that Reddit guy who full ported his Grandma’s inheritence. Hope he held! For you Nana!
English
59
22
2.1K
152.9K
Mohamed Osman
Mohamed Osman@MHosmanMD·
7 years between the two badges #AACR26 The 1st: a medical student in Egypt, receiving the 2019 AACR Global Scholar-in-Training Award The 2nd: a Postdoc Fellow at @WCMDeptofMed, receiving the 2025 AACR-EMD Serono Fellowship Deeply grateful to the @AACR for the continued support
Mohamed Osman tweet mediaMohamed Osman tweet media
English
4
4
79
11.8K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@docIzuog1995 @LocasaleLab I agree that some simple i terventions can outweigh drugs (exercise in crc, palliative in nsclc, acupuncture for hot flashes). I personally work on a study of malate in tnbc. The study u me tioned just need more n but is amazing. RAS inhib has been SO tough ergo hype re Revmed
English
0
0
0
52
Jason Locasale
Jason Locasale@LocasaleLab·
This is exactly the kind of hype and misrepresentation that has defined cancer research and oncology for decades. After 40+ years of work and well over $100B in taxpayer funding, what’s being presented as a revolution is a survival improvement of about 6–7 months. Patients don’t even get an additional birthday. This is now being hyped by the biotech industry and amplified by academic scientists as if it represents some fundamental breakthrough. It doesn’t. What’s even more concerning is that almost no one is calling this out. The same narrative gets repeated, the same approaches get reinforced, and the same cycle continues. Billions of taxpayer dollars will continue to fund this. Venture capital will continue to flow into biotech companies built around these claims. Pharma will continue to allocate time and resources here. Healthcare expenses for the public will continue to be greater than ever. Meanwhile, entire areas of cancer research and oncology practice—particularly early detection and prevention—remain neglected.
Anirban Maitra@Aiims1742

🚨🚨🚨 RASOLUTE-302 Ph3 is POSITIVE "Daraxonrasib demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy, with a hazard ratio of 0.40 (p < 0.0001)".... WOW! AMAZING news for patients with #PancreaticCancer The RAS Revolution is ON!! ir.revmed.com/news-releases/…

English
116
13
192
235.8K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@docIzuog1995 @LocasaleLab Not a PDAC onc (only breast), but a very promising signal from investigators. Note, though: 1) tiny sample (N=34 analyzed) 2) High burden: 2-hr infusions 3x/week. 3) Lacked diversity (94% white) 4) Unblinded. Phase 2 data is exciting, but a large Phase 3 is vital to confirm
English
3
0
0
44
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@VincentRK I agree partially. Technically, this is how humans learn as well. As we develop criticality, however, we weigh new information against prior facts/axioms and provide the probability of its truth value. I think AI will eventually be more "confident" in rejecting false premises.
English
1
0
1
98
Vincent Rajkumar
Vincent Rajkumar@VincentRK·
AI is not intelligent. It’s analyzing and stringing together content we generated and repackaging it. Yes, we can use AI wisely to our benefit, and make our lives easier. Like if I’m a doctor, and I need to solve a computer or coding problem, AI is immensely useful and incredibly fast and efficient. But I’m not kidding myself that it’s intelligent. It’s finding and linking and presenting to me information I don’t know that other intelligent humans who do know have generated before.
Hedgie@HedgieMarkets

🦔A researcher invented a fake eye condition called bixonimania, uploaded two obviously fraudulent papers about it to an academic server, and watched major AI systems present it as real medicine within weeks. The fake papers thanked Starfleet Academy, cited funding from the Professor Sideshow Bob Foundation and the University of Fellowship of the Ring, and stated mid-paper that the entire thing was made up. Google's Gemini told users it was caused by blue light. Perplexity cited its prevalence at one in 90,000 people. ChatGPT advised users whether their symptoms matched. The fake research was then cited in a peer-reviewed journal that only retracted it after Nature contacted the publisher. My Take The researcher made the papers as obviously fake as possible on purpose. The AI systems didn't catch it. Neither did the human researchers who cited it in real journals, which means people are feeding AI-generated references into their work without reading what they're actually citing. I've covered the FDA using AI for drug review, the NYC hospital CEO ready to replace radiologists, and ChatGPT Health launching this year. All of that is happening in the same environment where a condition funded by a Simpsons character and endorsed by the crew of the Enterprise was being presented as emerging medical consensus. The people making these deployment decisions seem to believe the pipeline from research to AI to patient is more supervised than it actually is. This experiment suggests it isn't supervised much at all. Hedgie🤗 nature.com/articles/d4158…

English
16
6
67
13.3K
The Maverick of Wall Street
The Maverick of Wall Street@TheMaverickWS·
Before the war: 1) Iran didn't control the Strait Of Hormuz, now it does 2) Iran oil was sanctioned, now it's not 3) Iran was not building a nuke, now it will 4) US bases in the Gulf were assets, now liabilities 5) Inflation was declining, now increasing Definitely winning!
The Maverick of Wall Street tweet media
English
1.6K
28.7K
97.2K
2.2M
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@AmandaT655870 @KrutikaKuppalli In a way this is truly the case. As many keep saying, AMG odds of matching are almost 3 times as IMGs. Rate is 93% vs 56% (before SOAP). We literally give applicants who are green cards/citizen, higher scores on cortex ranking. These programs do not get AMG applicants
English
0
0
0
38
Liza T
Liza T@AmandaT655870·
@Elkhanany @KrutikaKuppalli The average USMLE score in the US is 250. By 2nd/3rd year medial students! Not doctor with unlimited study time. There are enough eulogies US citizens to fill majority of residency spots and they should always be preferred. Even low scorers since they can never retake the test.
English
1
0
1
59
Krutika Kuppalli, MD FIDSA
Krutika Kuppalli, MD FIDSA@KrutikaKuppalli·
Wild to make assumptions about someone you don’t know. I was born and raised in the U.S., went to medical school here, work here, and have spent most of my career working in the most resource-limited settings in the world.
Officer Frenly (High IQ)@FrenlyOfficer

Indian has 0.7 active physicians per 1,000 people, America has 3.0 active physicians per 1,000 people. You are a liar. You are not motivated by increasing patient access to care. You just want to practice in America because you can make more money.

English
90
13
361
93.2K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@FrenlyOfficer I see your point. I would argue tho that GME stipends are fixed by inelastic CMS caps, not market supply. Programs can't hike pay to lure AMGs in residency. For tough specialties, AMG % vastly outnumber IMG per ERAS YoY. Real issue imo: -ve ROI for AMG but + for IMG still
English
0
0
0
102
Officer Frenly (High IQ)
Officer Frenly (High IQ)@FrenlyOfficer·
The vast majority of IMGs are generally exceptional people even among the physicians of the countries of where they come from. However, their ability to compete in the American labor market is a release valve that prevents residency programs and undesirable specialties from offering better salaries and better working conditions to their residence. They also prevent the number of physicians and undesirable specialties from dropping, which puts downward pressure on the salaries in the specialties and discourages American medical students from choosing those specialties.
Nisha Ukrani@NishaUkrani

Instead of mocking IMGs, be proud they’re willing to serve here. U.S. grads often match at top programs while many IMGs take the spots left behind. It takes immense sacrifice to get here. Mocking poorer countries and their doctors is shameful. I am proud of each and every IMG.

English
15
10
127
7.1K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@MaryBowdenMD So really you need to ask the US government as to why programs J1 G1, H1 and EB 1/2 exist. Also, why hasn’t governments subsidized medical education to allow for more local talent? I understand your point. But you’re asking the wrong people.
English
0
0
0
49
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@MaryBowdenMD The entire world has physician shortage. Most docs stay where they are born. Talented ones compete globally. If governments thrive on local talent alone, they would not have invented programs to recruit international talent.
English
1
0
0
87
Mary Talley Bowden MD
Mary Talley Bowden MD@MaryBowdenMD·
Do we really have a physician shortage? US is far ahead of Pakistan and India in terms of physician density, yet we keep getting told we need their doctors to survive.
Mary Talley Bowden MD tweet media
English
322
570
2.2K
587.7K
Ahmed Elkhanany
Ahmed Elkhanany@Elkhanany·
@KeruboSk I had many situations like that. My favorite reply is in to bask in the inefficiency of government in subsidizing medical education so there can be less doctor shortage. But that reply works too 😅🔥
English
0
1
7
2.4K
Sophia ❣️
Sophia ❣️@KeruboSk·
My colleague, a nephrologist: Hi, I’m Dr. Sundaram Patient: I’m not saying that. What’s your first name? Her: Doctor Patient: I don’t understand why there aren’t more doctors with regular American names like Johnson and Smith Her: Because they didn’t get into medical school, but if you’d like me to care for you, I’m happy to do that.
English
47
114
3.8K
176.3K